INV-050872), an Ideas Grant from the National Health and Medical Research Foundation to M.K.OB
Headaches, nausea, myalgia, fever, and chills are the most common adverse reactions, and they often occur immediately, during, or after the infusion
Li L, Shi LH, Jia J, Eltayeb O, Lu WJ, Tang YH, Dong C, Shuang SM
Youll likely notice the medication is working more powerfully
135,136 Based on these findings, CYP- and transporter-mediated DDIs involving peptide drugs are not negligible and should be carefully evaluated
Two names generating significant interest are mazdutide and tirzepatide, both of which have shown promising results